Your browser doesn't support javascript.
loading
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.
Barzegar, Mahdi; Vaheb, Saeed; Mirmosayyeb, Omid; Afshari-Safavi, Alireza; Nehzat, Nasim; Shaygannejad, Vahid.
Afiliación
  • Barzegar M; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Vaheb S; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Student Research Committee, Faculty of Paramedicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mirmosayyeb O; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Afshari-Safavi A; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Biostatistics and Epidemiology, Faculty of Health, North Khorasan University of Medical Sciences, Bojnurd, Iran.
  • Nehzat N; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Shaygannejad V; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: shaygannejad@med.mui.ac.ir.
Mult Scler Relat Disord ; 52: 102947, 2021 Jul.
Article en En | MEDLINE | ID: mdl-33979771

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Irán